Clinical Trial

riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU

Study acronym: SORCERER
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life? Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons. At the two-year follow-up, the health-related quality of life will be assessed
Trial Details
NCT Number NCT06552676
Lead Sponsor Azienda Usl di Bologna
Conditions Tracheostomy Complication, Quality of Life
Enrollment 300 participants
Start Date 2018-08-09
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-14